# REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke

Study · id `cardio:ct-nct07216170` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07216170](<https://clinicaltrials.gov/study/NCT07216170>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07216170

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07216170. Allocation not applicable; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07216170, source copy `cardio:ctgov-nct07216170-2026-05-26`, retrieved 2026-10-26)
- Planned start: 2026-12 (anticipated) (ClinicalTrials.gov record NCT07216170, source copy `cardio:ctgov-nct07216170-2026-05-26`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07216170, source copy `cardio:ctgov-nct07216170-2026-05-26`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07216170, source copy `cardio:ctgov-nct07216170-2026-05-26`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07216170-2026-05-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke
- Acronym: REVIVE
- Condition: Acute Ischemic Stroke
- Intervention (Device): SOFIA Flow 88 Aspiration Catheter
- Lead sponsor: Microvention-Terumo, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Bright Research Partners
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Microvention-Terumo, Inc. (`cardio:org-microvention-terumo-inc`)
- Registry lists this organization as a collaborator: Bright Research Partners (`cardio:org-bright-research-partners`)

## Provenance

Content hash: 7dfa66472ff944955683dd8813cf4d3a6f820ca9afb32d48976f9fd6ebb0d35b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
